Corcept Therapeutics CORT
NASDAQ CORT
$75.03 +2.26 (+3.11%)
At close: Nov 9, 2026 · 4:00 PM EST

Corcept Therapeutics (CORT) Net Income (2010 - 2026)

Updated

Corcept Therapeutics (CORT) recorded Net Income of $126.78 million in Q3 2026, up 544.6% from $19.67 million a year earlier and up 194.9% from the prior quarter.

Analysis

Corcept Therapeutics (CORT) Net Income (2010 - 2026) Analysis & Trends

On a TTM basis, Corcept Therapeutics' Net Income came in at $162.29 million as of Sep 30, 2026, up 52.9% year-over-year; for FY2025, it was $99.65 million, down 29.4% from FY2024.

  • Annual Net Income has a five-year compound annual growth rate of -1.2% (FY2020 to FY2025).
  • Across earlier years, Net Income came in at $141.21 million in FY2024 (+33.0%), $106.14 million in FY2023 (+4.7%), $101.42 million in FY2022 (-9.9%) and $112.51 million in FY2021 (+6.1%).
  • The Q3 2026 figure is the highest quarterly Net Income in data going back to Q2 2010.
  • On a year-over-year basis, Net Income rose in two of the last seven quarters, with growth averaging 65.5%.
  • Peak year-over-year performance for Net Income in the last five years was growth of 544.6% in Q3 2026, against a decline of 58.3% in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $42.99 million (Q2 2026), -$31.76 million (Q1 2026) and $24.29 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 210.00 Mn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 4.22 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 3.12 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 2.43 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 3.25 Bn
10 Corcept Therapeutics 7.99 Bn 6.60 Bn 335.86 Mn 126.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 126.78 Mn
Jun 30, 2026 42.99 Mn
Mar 31, 2026 -31.76 Mn
Dec 31, 2025 24.29 Mn
Sep 30, 2025 19.67 Mn
Jun 30, 2025 35.15 Mn
Mar 31, 2025 20.55 Mn
Dec 31, 2024 30.75 Mn
Sep 30, 2024 47.21 Mn
Jun 30, 2024 35.49 Mn
Mar 31, 2024 27.76 Mn
Dec 31, 2023 31.36 Mn
Sep 30, 2023 31.38 Mn
Jun 30, 2023 27.53 Mn
Mar 31, 2023 15.88 Mn
Dec 31, 2022 16.60 Mn
Sep 30, 2022 34.61 Mn
Jun 30, 2022 27.41 Mn
Mar 31, 2022 22.80 Mn
Dec 31, 2021 32.05 Mn
API Access

Corcept Therapeutics Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=CORT&period=max&api_key=YOUR_API_KEY